Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
1 study found for:    15583076 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study (0954-133)
Condition: Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)
Interventions: Drug: MK0954,   /Duration of Treatment : 5 Years;   Drug: Comparator : atenolol /Duration of Treatment : 5 Years
To Top

† Indicates status has not been verified in more than two years